BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9031895)

  • 21. Combined treatment of portal hypertension with ritanserin and propranolol in conscious and unrestrained cirrhotic rats.
    Pomier-Layrargues G; Giroux L; Rocheleau B; Huet PM
    Hepatology; 1992 May; 15(5):878-82. PubMed ID: 1568730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of portal hypertension by propranolol and spironolactone in rats with bile duct ligation.
    Oberti F; Rifflet H; Maïga MY; Pilette C; Gallois Y; Douay O; Le Jeune JJ; Saumet JL; Calès P
    J Hepatol; 1997 Jan; 26(1):167-73. PubMed ID: 9148008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the administration of pentoxifylline and prednisolone on the evolution of portal fibrogenesis secondary to biliary obstruction-an experimental study in growing animals.
    Andrade Wde C; Tannuri U; da Silva LF; Alves VA
    J Pediatr Surg; 2009 Nov; 44(11):2071-7. PubMed ID: 19944210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute hemodynamic changes following hemorrhage and volume restitution, using a low viscosity plasma expander, in anesthetized portal hypertensive rats.
    Hilzenrat N; Arish A; Yaari A; Sikuler E
    J Hepatol; 1999 Nov; 31(5):874-9. PubMed ID: 10580585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic characterization in experimental liver cirrhosis induced by thioacetamide administration.
    Hori N; Okanoue T; Sawa Y; Mori T; Kashima K
    Dig Dis Sci; 1993 Dec; 38(12):2195-202. PubMed ID: 8261820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amiloride reduces portal hypertension in rat liver cirrhosis.
    Steib CJ; Hennenberg M; Beitinger F; Hartmann AC; Bystron M; De Toni EN; Gerbes AL
    Gut; 2010 Jun; 59(6):827-36. PubMed ID: 20551467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pentoxifylline reduces nephrotoxicity associated with cyclosporine in the rat by its rheological properties.
    Albornoz LE; Sanchez SB; Bandi JC; Canteros G; de las Heras M; Mastai RC
    Transplantation; 1997 Nov; 64(10):1404-7. PubMed ID: 9392302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of a clonidine-induced decrease in portal pressure in normal and cirrhotic conscious rats.
    Roulot D; Braillon A; Gaudin C; Ozier Y; Girod C; Lebrec D
    Hepatology; 1989 Oct; 10(4):477-81. PubMed ID: 2777209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early colchicine administration reduces hepatic fibrosis and portal hypertension in rats with bile duct ligation.
    Poo JL; Feldmann G; Moreau A; Gaudin C; Lebrec D
    J Hepatol; 1993 Aug; 19(1):90-4. PubMed ID: 8301049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mixed endothelin receptor antagonist, SB209670, decreases portal pressure in biliary cirrhotic rats in vivo by reducing portal venous system resistance.
    Kojima H; Yamao J; Tsujimoto T; Uemura M; Takaya A; Fukui H
    J Hepatol; 2000 Jan; 32(1):43-50. PubMed ID: 10673066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats.
    Pizcueta MP; de Lacy AM; Kravetz D; Bosch J; Rodés J
    Hepatology; 1989 Dec; 10(6):953-7. PubMed ID: 2583690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting.
    Kravetz D; Bosch J; Arderiu M; Pilar Pizcueta M; Rodés J
    Hepatology; 1989 Jun; 9(6):808-14. PubMed ID: 2714733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pentoxifylline attenuates the increase in whole blood viscosity after transfusion.
    Bacher A; Eggensperger E; Koppensteiner R; Mayer N; Klimscha W
    Acta Anaesthesiol Scand; 2005 Jan; 49(1):41-6. PubMed ID: 15675980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients.
    Colle I; De Vriese AS; Van Vlierberghe H; Lameire NH; DeVos M
    Liver Int; 2004 Feb; 24(1):63-8. PubMed ID: 15102002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
    Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
    Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of intravariceal pressure with pentoxifylline: a possible new approach in the treatment of portal hypertension.
    Eleftheriadis E; Kotzampassi K; Koufogiannis D
    Am J Gastroenterol; 1998 Dec; 93(12):2431-5. PubMed ID: 9860404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Capsaicin treatment blocks development of hyperkinetic circulation in portal hypertensive and cirrhotic rats.
    Lee SS; Sharkey KA
    Am J Physiol; 1993 May; 264(5 Pt 1):G868-73. PubMed ID: 8498513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Portal hypertension and blood viscosity.
    Sikuler E
    J Clin Gastroenterol; 2007; 41 Suppl 3():S262-5. PubMed ID: 17975475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilioenteric anastomosis reverses hyperkinetic circulation in bile duct-ligated cirrhotic rats.
    Jalink D; Urbanski SJ; Lee SS
    J Hepatol; 1996 Dec; 25(6):924-31. PubMed ID: 9007722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by oestrogen.
    Sakamoto M; Ueno T; Nakamura T; Sakata R; Hasimoto O; Torimura T; Sata M
    Eur J Clin Invest; 2005 Mar; 35(3):220-5. PubMed ID: 15733078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.